Dr. Christopher R. Trevino
Claim this profileTulane University Health Sciences Center
Studies Cancer
Studies Tumors
10 reported clinical trials
37 drugs studied
Area of expertise
1Cancer
Stage IV
PD-L1 positive
NTRK positive
2Tumors
Stage IV
PD-L1 positive
NTRK positive
Affiliated Hospitals
Clinical Trials Christopher R. Trevino is currently running
Radium-223 + Cabozantinib
for Kidney Cancer with Bone Metastasis
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
Targeted Therapy
for Brain Cancer
This phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK, ROS1, CDK, PI3K, or KRAS G12C. Medications that target these genes such as abemaciclib, paxalisib, entrectinib and adagrasib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Genetic testing may help doctors tailor treatment for each mutation.
Recruiting1 award Phase 217 criteria
More about Christopher R. Trevino
Clinical Trial Related7 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Christopher R. Trevino has experience with
- Ipilimumab
- Nivolumab
- Cabozantinib
- Berubicin
- Lomustine
- Radiation Therapy
Breakdown of trials Christopher R. Trevino has run
Cancer
Tumors
Glioblastoma
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher R. Trevino specialize in?
Christopher R. Trevino focuses on Cancer and Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Christopher R. Trevino currently recruiting for clinical trials?
Yes, Christopher R. Trevino is currently recruiting for 4 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Christopher R. Trevino has studied deeply?
Yes, Christopher R. Trevino has studied treatments such as Ipilimumab, Nivolumab, Cabozantinib.
What is the best way to schedule an appointment with Christopher R. Trevino?
Apply for one of the trials that Christopher R. Trevino is conducting.
What is the office address of Christopher R. Trevino?
The office of Christopher R. Trevino is located at: Tulane University Health Sciences Center, New Orleans, Louisiana 70112 United States. This is the address for their practice at the Tulane University Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.